Study ID: LAQ-MS-306 | 2013-002082-19
Study Title
- A Study to Evaluate 2 Doses Of Oral Administration Of Laquinimod Compared to Interferon ֳ-1a Administered by Injection in Participants With Relapsing Remitting Multiple Sclerosis (RRMS)
Teva Identifier
- LAQ-MS-306 | 2013-002082-19
ClinicalTrials.gov Identifier
- NCT01975298
Study Status
- Withdrawn
Trial Condition(s)
- Relapsing Remitting Multiple Sclerosis
Interventions
- Drug: Laquinimod | Drug: Avonexֲ®
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years to 55 Years
Trial Duration
- 01/01/2014 - 03/01/2014
Phase
- Phase 3
Study Type
Interventional
